EVAX Reports 86% Vaccine Target Precision, $12M Revenue, +94% YoY Growth, Phase 2 EVX-01 Trial Success
Evaxion A/S American Depositary Share · Now $3.90
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS